Pekka Kohonen

Publications
Public outreach and news

Articles

Article: NATURE NANOTECHNOLOGY. 2021;16(6):644-654

Towards FAIR nanosafety data.

Jeliazkova N; Apostolova MD; Andreoli C; Barone F; Barrick A; Battistelli C; Bossa C; Botea-Petcu A; Châtel A; De Angelis I; Dusinska M; El Yamani N; Gheorghe D; Giusti A; Gómez-Fernández P; Grafström R; Gromelski M; Jacobsen NR; Jeliazkov V; Jensen KA; Kochev N; Kohonen P; Manier N; Mariussen E; Mech A; Navas JM; Paskaleva V; Precupas A; Puzyn T; Rasmussen K; Ritchie P; Llopis IR; Rundén-Pran E; Sandu R; Shandilya N; Tanasescu S; Haase A; Nymark P
Article: NANOMATERIALS. 2020;10(12):E2493-2493

Can an InChI for Nano Address the Need for a Simplified Representation of Complex Nanomaterials across Experimental and Nanoinformatics Studies?

Lynch I; Afantitis A; Exner T; Himly M; Lobaskin V; Doganis P; Maier D; Sanabria N; Papadiamantis AG; Rybinska-Fryca A; Gromelski M; Puzyn T; Willighagen E; Johnston BD; Gulumian M; Matzke M; Green Etxabe A; Bossa N; Serra A; Liampa I; Harper S; Tämm K; Jensen AC; Kohonen P; Slater L; Tsoumanis A; Greco D; Winkler DA; Sarimveis H; Melagraki G
Article: TOXICOLOGY IN VITRO. 2019;54:23-32

Integrated analysis of in vitro data and the adverse outcome pathway framework for prioritization and regulatory applications: An exploratory case study using publicly available data on piperonyl butoxide and liver models.

Oki NO; Farcal L; Abdelaziz A; Florean O; Doktorova TY; Exner T; Kohonen P; Grafström R; Hardy B
Article: JOURNAL OF CHEMICAL INFORMATION AND MODELING. 2018;58(3):543-549

toxFlow: A Web-Based Application for Read-Across Toxicity Prediction Using Omics and Physicochemical Data.

Varsou D-D; Tsiliki G; Nymark P; Kohonen P; Grafström R; Sarimveis H
Article: TOXICOLOGICAL SCIENCES. 2018;162(1):264-275

A Data Fusion Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions.

Nymark P; Rieswijk L; Ehrhart F; Jeliazkova N; Tsiliki G; Sarimveis H; Evelo CT; Hongisto V; Kohonen P; Willighagen E; Grafström RC
Article: SCIENTIFIC REPORTS. 2018;8(1):1115

Macrophage sensing of single-walled carbon nanotubes via Toll-like receptors.

Mukherjee SP; Bondarenko O; Kohonen P; Andón FT; Brzicová T; Gessner I; Mathur S; Bottini M; Calligari P; Stella L; Kisin E; Shvedova A; Autio R; Salminen-Mankonen H; Lahesmaa R; Fadeel B
Article: SMALL METHODS. 2017;1(11)

Enriching Nanomaterials Omics Data: An Integration Technique to Generate Biological Descriptors

Tsiliki G; Nymark P; Kohonen P; Grafstrom R; Sarimveis H
Article: JOURNAL OF BIOMEDICAL SEMANTICS. 2017;8(1):35

RDFIO: extending Semantic MediaWiki for interoperable biomedical data management.

Lampa S; Willighagen E; Kohonen P; King A; Vrandečić D; Grafström R; Spjuth O
Article: NATURE COMMUNICATIONS. 2017;8:15932

A transcriptomics data-driven gene space accurately predicts liver cytopathology and drug-induced liver injury.

Kohonen P; Parkkinen JA; Willighagen EL; Ceder R; Wennerberg K; Kaski S; Grafström RC
Article: EUROPEAN UROLOGY. 2016;69(6):1120-1128

Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue.

Aakula A; Kohonen P; Leivonen S-K; Mäkelä R; Hintsanen P; Mpindi JP; Martens-Uzunova E; Aittokallio T; Jenster G; Perälä M; Kallioniemi O; Östling P
Article: JOURNAL OF MOLECULAR BIOCHEMISTRY. 2016;5(1):12-22

High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer.

Ketola K; Viitala M; Kohonen P; Fey V; Culig Z; Kallioniemi O; Iljin K
Article: ATLA-ALTERNATIVES TO LABORATORY ANIMALS. 2015;43(5):325-332

Toward the Replacement of Animal Experiments through the Bioinformatics-driven Analysis of 'Omics' Data from Human Cell Cultures.

Grafström RC; Nymark P; Hongisto V; Spjuth O; Ceder R; Willighagen E; Hardy B; Kaski S; Kohonen P
Article: EUROPEAN UROLOGY. 2015;68(4):581-588

miR-183 in prostate cancer cells positively regulates synthesis and serum levels of prostate-specific antigen.

Larne O; Östling P; Haflidadóttir BS; Hagman Z; Aakula A; Kohonen P; Kallioniemi O; Edsjö A; Bjartell A; Lilja H; Lundwall Å; Ceder Y
Article: INTERNATIONAL JOURNAL OF CANCER. 2015;136(11):2535-2545

Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions.

Saeed K; Östling P; Björkman M; Mirtti T; Alanen K; Vesterinen T; Sankila A; Lundin J; Lundin M; Rannikko A; Nordling S; Mpindi J-P; Kohonen P; Iljin K; Kallioniemi O; Rantala JK
Article: ACS NANO. 2015;9(1):146-163

Next-generation sequencing reveals low-dose effects of cationic dendrimers in primary human bronchial epithelial cells.

Feliu N; Kohonen P; Ji J; Zhang Y; Karlsson HL; Palmberg L; Nyström A; Fadeel B
Article: BEILSTEIN JOURNAL OF NANOTECHNOLOGY. 2015;6:1609-1634

The eNanoMapper database for nanomaterial safety information.

Jeliazkova N; Chomenidis C; Doganis P; Fadeel B; Grafström R; Hardy B; Hastings J; Hegi M; Jeliazkov V; Kochev N; Kohonen P; Munteanu CR; Sarimveis H; Smeets B; Sopasakis P; Tsiliki G; Vorgrimmler D; Willighagen E
Article: PLOS ONE. 2015;10(10):e0129008

Proteomics Analysis Reveals Distinct Corona Composition on Magnetic Nanoparticles with Different Surface Coatings: Implications for Interactions with Primary Human Macrophages.

Vogt C; Pernemalm M; Kohonen P; Laurent S; Hultenby K; Vahter M; Lehtiö J; Toprak MS; Fadeel B
Article: ONCOGENE. 2014;33(27):3538-3549

Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis.

He T; Haapa-Paananen S; Kaminskyy VO; Kohonen P; Fey V; Zhivotovsky B; Kallioniemi O; Perälä M
Article: JOURNAL OF CELL BIOLOGY. 2014;204(5):713-727

CIP2A oncoprotein controls cell growth and autophagy through mTORC1 activation.

Puustinen P; Rytter A; Mortensen M; Kohonen P; Moreira JM; Jäättelä M
Article: CELL DEATH & DISEASE. 2014;5(1):e1043

Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells.

Pavet V; Shlyakhtina Y; He T; Ceschin DG; Kohonen P; Perälä M; Kallioniemi O; Gronemeyer H
Article: CARCINOGENESIS. 2013;34(2):436-445

Novel pyrimidine-2,4-diamine derivative suppresses the cell viability and spindle assembly checkpoint activity by targeting Aurora kinases.

Salmela A-L; Pouwels J; Mäki-Jouppila J; Kohonen P; Toivonen P; Kallio L; Kallio M
Article: MOLECULAR INFORMATICS. 2013;32(1):47-63

The ToxBank Data Warehouse: Supporting the Replacement of In Vivo Repeated Dose Systemic Toxicity Testing.

Kohonen P; Benfenati E; Bower D; Ceder R; Crump M; Cross K; Grafström RC; Healy L; Helma C; Jeliazkova N; Jeliazkov V; Maggioni S; Miller S; Myatt G; Rautenberg M; Stacey G; Willighagen E; Wiseman J; Hardy B
Article: PLOS ONE. 2013;8(4):e60930

Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.

Haapa-Paananen S; Chen P; Hellström K; Kohonen P; Hautaniemi S; Kallioniemi O; Perälä M
Article: ONCOGENE. 2012;31(29):3444-3456

Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion.

Björkman M; Östling P; Härmä V; Virtanen J; Mpindi J-P; Rantala J; Mirtti T; Vesterinen T; Lundin M; Sankila A; Rannikko A; Kaivanto E; Kohonen P; Kallioniemi O; Nees M
Article: PROSTATE. 2012;72(7):789-802

Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer.

Vainio P; Wolf M; Edgren H; He T; Kohonen P; Mpindi J-P; Smit F; Verhaegh G; Schalken J; Perälä M; Iljin K; Kallioniemi O
Article: ONCOGENE. 2012;31(16):2075-2089

Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models.

Härmä V; Knuuttila M; Virtanen J; Mirtti T; Kohonen P; Kovanen P; Happonen A; Kaewphan S; Ahonen I; Kallioniemi O; Grafström R; Lötjönen J; Nees M
Article: MOLECULAR CELL. 2012;45(6):764-776

ErbB2-driven breast cancer cell invasion depends on a complex signaling network activating myeloid zinc finger-1-dependent cathepsin B expression.

Rafn B; Nielsen CF; Andersen SH; Szyniarowski P; Corcelle-Termeau E; Valo E; Fehrenbacher N; Olsen CJ; Daugaard M; Egebjerg C; Bøttzauw T; Kohonen P; Nylandsted J; Hautaniemi S; Moreira J; Jäättelä M; Kallunki T
Article: ONCOGENE. 2012;31(10):1299-1310

HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation.

Haapa-Paananen S; Kiviluoto S; Waltari M; Puputti M; Mpindi JP; Kohonen P; Tynninen O; Haapasalo H; Joensuu H; Perälä M; Kallioniemi O
Article: PLOS ONE. 2012;7(6):e39801

High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer.

Vainio P; Mpindi J-P; Kohonen P; Fey V; Mirtti T; Alanen KA; Perälä M; Kallioniemi O; Iljin K
Article: MOLECULAR & CELLULAR PROTEOMICS. 2011;10(7):m110.005322

Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impact.

Leivonen S-K; Rokka A; Ostling P; Kohonen P; Corthals GL; Kallioniemi O; Perälä M
Article: CANCER RESEARCH. 2011;71(5):1956-1967

Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.

Östling P; Leivonen S-K; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
Article: PLOS ONE. 2011;6(2):e17259

GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasets.

Mpindi JP; Sara H; Haapa-Paananen S; Kilpinen S; Pisto T; Bucher E; Ojala K; Iljin K; Vainio P; Björkman M; Gupta S; Kohonen P; Nees M; Kallioniemi O
Article: AMERICAN JOURNAL OF PATHOLOGY. 2011;178(2):525-536

Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer.

Vainio P; Gupta S; Ketola K; Mirtti T; Mpindi J-P; Kohonen P; Fey V; Perälä M; Smit F; Verhaegh G; Schalken J; Alanen KA; Kallioniemi O; Iljin K
Article: BREAST CANCER RESEARCH AND TREATMENT. 2011;125(2):421-430

Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis.

Pollari S; Käkönen S-M; Edgren H; Wolf M; Kohonen P; Sara H; Guise T; Nees M; Kallioniemi O
Article: GENOME MEDICINE. 2010;2(9):65

Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme.

Ovaska K; Laakso M; Haapa-Paananen S; Louhimo R; Chen P; Aittomäki V; Valo E; Núñez-Fontarnau J; Rantanen V; Karinen S; Nousiainen K; Lahesmaa-Korpinen A-M; Miettinen M; Saarinen L; Kohonen P; Wu J; Westermarck J; Hautaniemi S
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2010;40(9):2599-2607

Concerted action of Helios and Ikaros controls the expression of the inositol 5-phosphatase SHIP.

Alinikula J; Kohonen P; Nera K-P; Lassila O
Article: PLOS ONE. 2010;5(5):e10431

A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses.

Härmä V; Virtanen J; Mäkelä R; Happonen A; Mpindi J-P; Knuuttila M; Kohonen P; Lötjönen J; Kallioniemi O; Nees M
Article: BMC CANCER. 2010;10:7

Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase.

Mattila E; Marttila H; Sahlberg N; Kohonen P; Tähtinen S; Halonen P; Perälä M; Ivaska J
Article: ONCOGENE. 2009;28(44):3926-3936

Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.

Leivonen S-K; Mäkelä R; Ostling P; Kohonen P; Haapa-Paananen S; Kleivi K; Enerly E; Aakula A; Hellström K; Sahlberg N; Kristensen VN; Børresen-Dale A-L; Saviranta P; Perälä M; Kallioniemi O
Article: CLINICAL CANCER RESEARCH. 2009;15(19):6070-6078

High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.

Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
Article: IMMUNITY. 2006;24(3):283-293

Loss of Pax5 promotes plasma cell differentiation.

Nera K-P; Kohonen P; Narvi E; Peippo A; Mustonen L; Terho P; Koskela K; Buerstedde J-M; Lassila O
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2005;62(3):218-223

Development of early PCLP1-expressing haematopoietic cells within the avian dorsal aorta.

Suonpää P; Kohonen P; Koskela K; Koskiniemi H; Salminen-Mankonen H; Lassila O
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2004;60(1-2):100-107

Avian Helios and evolution of the Ikaros family.

Kohonen P; Nera K-P; Lassila O
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2004;59(5):449-457

Chicken B-cell-activating factor: regulator of B-cell survival in the bursa of fabricius.

Koskela K; Nieminen P; Kohonen P; Salminen H; Lassila O
Article: IMMUNOGENETICS. 2004;55(12):845-854

Identification of a novel cytokine-like transcript differentially expressed in avian gammadelta T cells.

Koskela K; Kohonen P; Salminen H; Uchida T; Buerstedde J-M; Lassila O
Article: IMMUNOGENETICS. 2003;55(6):412-422

Insight into lymphoid development by gene expression profiling of avian B cells.

Koskela K; Kohonen P; Nieminen P; Buerstedde J-M; Lassila O
Show more

All other publications

Editorial comment: NATURE NANOTECHNOLOGY. 2022;17(1):19-20

Reply to: Prospects and challenges for FAIR toxicogenomics data.

Grafström R; Haase A; Kohonen P; Jeliazkova N; Nymark P
Review: NANOMATERIALS. 2020;10(5):E903-903

Transcriptomics in Toxicogenomics, Part II: Preprocessing and Differential Expression Analysis for High Quality Data.

Federico A; Serra A; Ha MK; Kohonen P; Choi J-S; Liampa I; Nymark P; Sanabria N; Cattelani L; Fratello M; Kinaret PAS; Jagiello K; Puzyn T; Melagraki G; Gulumian M; Afantitis A; Sarimveis H; Yoon T-H; Grafström R; Greco D
Review: NANOMATERIALS. 2020;10(4):E750-750

Transcriptomics in Toxicogenomics, Part I: Experimental Design, Technologies, Publicly Available Data, and Regulatory Aspects.

Kinaret PAS; Serra A; Federico A; Kohonen P; Nymark P; Liampa I; Ha MK; Choi J-S; Jagiello K; Sanabria N; Melagraki G; Cattelani L; Fratello M; Sarimveis H; Afantitis A; Yoon T-H; Gulumian M; Grafström R; Puzyn T; Greco D
Review: NANOMATERIALS. 2020;10(4):E708-708

Transcriptomics in Toxicogenomics, Part III: Data Modelling for Risk Assessment.

Serra A; Fratello M; Cattelani L; Liampa I; Melagraki G; Kohonen P; Nymark P; Federico A; Kinaret PAS; Jagiello K; Ha MK; Choi J-S; Sanabria N; Gulumian M; Puzyn T; Yoon T-H; Sarimveis H; Grafström R; Afantitis A; Greco D
Review: SMALL. 2020;16(6):e1904749

Toward Rigorous Materials Production: New Approach Methodologies Have Extensive Potential to Improve Current Safety Assessment Practices.

Nymark P; Bakker M; Dekkers S; Franken R; Fransman W; García-Bilbao A; Greco D; Gulumian M; Hadrup N; Halappanavar S; Hongisto V; Hougaard KS; Jensen KA; Kohonen P; Koivisto AJ; Dal Maso M; Oosterwijk T; Poikkimäki M; Rodriguez-Llopis I; Stierum R; Sørli JB; Grafström R
Review: COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL. 2020;18:583-602

NanoSolveIT Project: Driving nanoinformatics research to develop innovative and integrated tools for in silico nanosafety assessment.

Afantitis A; Melagraki G; Isigonis P; Tsoumanis A; Varsou DD; Valsami-Jones E; Papadiamantis A; Ellis L-JA; Sarimveis H; Doganis P; Karatzas P; Tsiros P; Liampa I; Lobaskin V; Greco D; Serra A; Kinaret PAS; Saarimäki LA; Grafström R; Kohonen P; Nymark P; Willighagen E; Puzyn T; Rybinska-Fryca A; Lyubartsev A; Alstrup Jensen K; Brandenburg JG; Lofts S; Svendsen C; Harrison S; Maier D; Tamm K; Jänes J; Sikk L; Dusinska M; Longhin E; Rundén-Pran E; Mariussen E; El Yamani N; Unger W; Radnik J; Tropsha A; Cohen Y; Leszczynski J; Ogilvie Hendren C; Wiesner M; Winkler D; Suzuki N; Yoon TH; Choi J-S; Sanabria N; Gulumian M; Lynch I
Published conference paper: ANNALS OF THE AMERICAN THORACIC SOCIETY. 2018;15(Suppl 2):S91-S97

Toxic and Genomic Influences of Inhaled Nanomaterials as a Basis for Predicting Adverse Outcome.

Nymark P; Kohonen P; Hongisto V; Grafström RC
Meeting abstract: TOXICOLOGY LETTERS. 2016;258:S118-S119

eNanoMapper - A database and ontology framework for design and safety assessment of nanomaterials

Kilic G; Fadeel B; Farcal L; Sarimveis H; Doganis P; Drakakis G; Tsiliki G; Chomenidis C; Helma C; Rautenberg M; Gebele D; Jeliazkova N; Kochev N; Owen G; Chang J; Willighagen EL; Ehrhart F; Rieswijk L; Hongisto V; Nymark P; Kohonen P; Grafstrom R; Hardy B
Review: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2014;115(1):50-58

Cancer biology, toxicology and alternative methods development go hand-in-hand.

Kohonen P; Ceder R; Smit I; Hongisto V; Myatt G; Hardy B; Spjuth O; Grafström R
Meeting abstract: CANCER RESEARCH. 2013;73(8):4032

Transcriptomics analyses of normal and transformed keratinocyte lines generated novel biomarkers for prognosticating outcome in head and neck cancer

Grafstrom RC; Merne M; Kohonen P; Jerhammar F; Nees M; Roberg K; Ceder R
Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2012;48:S140

Precursor MicroRNA Functional Profiling Identifies MicroRNAs Essential for Glioblastoma Proliferation

Haapa-Paananen S; Chen P; Hautaniemi S; Kohonen P; Perala M; Kallioniemi O
Meeting abstract: TOXICOLOGY LETTERS. 2012;211:S40

Genotoxic and epigenetic effects of silver nanoparticles

Karlsson H; Gliga AR; Kohonen P; Wallberg A; Fadeel B
Corrigendum: BREAST CANCER RESEARCH AND TREATMENT. 2012;131(3):1085-1086

Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis (vol 125, pg 421, 2011)

Pollari S; Kakonen S-M; Edgren H; Wolf M; Kohonen P; Sara H; Guise T; Nees M; Kallioniemi O
Meeting abstract: CANCER RESEARCH. 2011;71:3977

Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells

Ostling P; Leivonen S-K; Aakula A; Kohonen P; Makela R; Hagman Z; Edsjo A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perala M; Kallioniemi O
Meeting abstract: CANCER RESEARCH. 2011;71:3800

HES6 gene is a strong glioma biomarker and a key transcriptional regulator needed for cancer cell growth

Haapa-Paananen SM; Kiviluoto S; Waltari M; Puputti M; Mpindi J-P; Kohonen P; Tynninen O; Haapasalo H; Joensuu H; Perala M; Kallioniemi O
Meeting abstract: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2010;8(7):177

Systematic functional analysis of microRNAs by transfection of 1129 miRNAs into prostate cancer cells

Bjerkvig R; Leivonen SK; Ostling P; Aakula A; Kohonen P; Makela R; Hagman Z; Edgren H; Ceder Y; Perala M; Kallioniemi O
Meeting abstract: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2010;8(5):61-62

Drugs with known pharmacological profiles, such as monensin, disulfiram and salinomycin, show cancer-selective inhibition of prostate cancer cell growth by increasing oxidative stress

Ketola K; Vainio P; Fey V; Kohonen P; Kallioniemi O; Iljin K
Meeting abstract: CANCER RESEARCH. 2010;70:2072

Systematic functional analysis of microRNAs by transfection of 1129 miRNAs into prostate cancer cells

Ostling P; Leivonen S-K; Aakula A; Kohonen P; Makela R; Perala M; Kallioniemi O
Meeting abstract: CANCER RESEARCH. 2010;70:1953

Functional identification of microRNA targets by integrated proteomics and microarray profiling: miR-193b in breast cancer

Leivonen S-K; Rokka A; Ostling P; Kohonen P; Corthals G; Perala M; Kallioniemi O
Meeting abstract: BONE. 2010;47:S291

Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis

Pollari S; Kakonen S; Edgren H; Wolf M; Kohonen P; Sara H; Guise T; Nees M; Kallioniemi O
Meeting abstract: CANCER TREATMENT REVIEWS. 2008;34:S65

MicroRNA expression profiling and functional screening in bone metastatic breast cancer cells

Pollari S; Hellstrom K; Haapa-Paananen S; Leivonena S-K; Kohonen P; Sahberg N; Perala M; Kakonen S-M; Nees M; Kattioniemi O
Review: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2007;66(2-3):113-121

Avian model for B-cell immunology--new genomes and phylotranscriptomics.

Kohonen P; Nera K-P; Lassila O
Published conference paper: NANOPARTICLES FOR RATIONAL VACCINE DESIGN. 2000;251:51-58

The Ikaros family and the development of early intraembryonic hematopoietic stem cells.

Liippo J; Nera KP; Kohonen P; Lampisuo M; Koskela K; Nieminen P; Lassila O
Show more

Articles

All other publications

News from KI

Events from KI